Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy-Reference-Cited by-同舟云学术

Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy

Published:1993-10 Issue:1-2 Volume:10 Page:35-45
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Trillet-Lenoir Véronique,Mornex Françoise,Chauvin Franck,Fournel Pierre,Voloch Alain,Perol Maurice,Laennec Eric,Piperno Daniel,Boyer Jacques,Ardiet Jean-Michel,Carrie Christian,Montbarbon Xavier,Marquis Isabelle,Romestaing Pascale,Méré Pascale,Talabard Jean-Noël,Chassard Jean-Louis,Gérard Jean-Pierre,Schmitt Thierry,Guérin Jean-Claude

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer;Bunn;Ann Int Med,1987

2. Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung;Perry;N Engl J Med,1987

3. Ten-year survival of patients with small cell lung cancer treated with combination chemotherapy with or without irradiation;Johnson;J Clin Oncol,1990

4. Randomized trial of radiotherapy to the thorax in limited small cell carcinoma of the lung treated with multiagent radiotherapy and elective brain irradiation;Perez,1984

5. Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease;Arriagada;Int J Radiat Oncol Biol Phys,1985

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients;British Journal of Cancer;2017-01

2. The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT);Lung Cancer;2001-03

3. Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study;British Journal of Clinical Pharmacology;2000-10

4. Small-cell lung cancer: Patients included in clinical trials are not representative of the patient population as a whole;Annals of Oncology;1999-07

5. Alternating radiotherapy and chemotherapy in limited disease small cell lung cancer;Radiotherapy and Oncology;1998-03